Literature DB >> 7860453

Whole blood serotonin and disruptive behaviors in juvenile obsessive-compulsive disorder.

G L Hanna1, A Yuwiler, J K Coates.   

Abstract

OBJECTIVE: The study was conducted with children and adolescents with obsessive-compulsive disorder (OCD) to assess the relationship of whole blood serotonin (5-HT) content to a concurrent diagnosis of a disruptive behavior disorder (DBD) and to severity ratings of aggressive behavior.
METHOD: Eighteen children and adolescents who met DSM-III-R criteria for OCD were evaluated with a structured interview, clinician rating scales, and the Child Behavior Checklist (CBCL). Blood 5-HT concentration was assayed with a fluorometric procedure. Relationships among categorical diagnoses, dimensional ratings, and blood 5-HT content were analyzed with bivariate and multivariate techniques.
RESULTS: OCD subjects with a DBD (n = 6) had significantly higher scores than those without a DBD (n = 12) on the Total Problem scale, the Externalizing Problem scale, and several of the behavioral syndrome scales of the CBCL. Blood 5-HT concentrations were significantly lower in those with a DBD than in those without a DBD, and blood 5-HT concentrations had significant negative correlations with the Total score, the Externalizing score, and the Aggressive Behavior score of the CBCL.
CONCLUSIONS: The results provide further evidence of a significant relationship between aggressive behavior and serotonergic functioning.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860453     DOI: 10.1097/00004583-199501000-00010

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  8 in total

1.  Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.

Authors:  Richard Delorme; Catalina Betancur; Jacques Callebert; Nadia Chabane; Jean-Louis Laplanche; Marie-Christine Mouren-Simeoni; Jean-Marie Launay; Marion Leboyer
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

2.  Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder.

Authors:  Audra K Langley; Adam B Lewin; R Lindsey Bergman; Joyce C Lee; John Piacentini
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-03-28       Impact factor: 4.785

3.  The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes.

Authors:  Beatrice A Golomb; Michael H Criqui; Halbert L White; Joel E Dimsdale
Journal:  Control Clin Trials       Date:  2004-04

4.  Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates.

Authors:  Caleb W Lack; Eric A Storch; Mary L Keeley; Gary R Geffken; Emily D Ricketts; Tanya K Murphy; Wayne K Goodman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-03       Impact factor: 4.328

5.  A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD).

Authors:  Javad Alaghband-Rad; Mitra Hakimshooshtary
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-02-03       Impact factor: 4.785

6.  The heterogeneity of disruptive behavior disorders - implications for neurobiological research and treatment.

Authors:  Christina Stadler; Fritz Poustka; Philipp Sterzer
Journal:  Front Psychiatry       Date:  2010-10-11       Impact factor: 4.157

7.  Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial.

Authors:  Beatrice A Golomb; Joel E Dimsdale; Hayley J Koslik; Marcella A Evans; Xun Lu; Steven Rossi; Paul J Mills; Halbert L White; Michael H Criqui
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

8.  Exploring aspects of the cognitive behavioural model of physical hoarding in relation to digital hoarding behaviours.

Authors:  Susan Thorpe; Alexander Bolster; Nick Neave
Journal:  Digit Health       Date:  2019-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.